x



Share this page.


Previous CCT Meetings and Webinars


  • Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic—March 11, 2017, Baltimore, Maryland
  • Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment—November 2–4, 2016, Tysons, Virginia
  • The Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk—October 25–26, 2016, Arlington, Virginia
  • Ocular Toxicology, Pharmacology and Drug Delivery: An Eye on the Future—June 27 & 28, 2016, South San Francisco, California
  • MiRNA Biomarkers for Toxicology—March 12, 2016, New Orleans, Louisiana
  • FutureTox III: Transforming 21st Century Science into Risk Assessment and Regulatory Decision-Making—November 19–20, 2015, Arlington, Virginia
  • Risk Assessment of Humanized Monoclonal Antibodies and Antibody—Drug Conjugates; and Risk Assessment of Oligonucleotide Constructs—April 16, 2015, Webinar
  • Regulatory Toxicology Testing for Small Molecules: Strategies and Outcome Analysis; and Risk Assessment of “Traditional” Biologics—February 25, 2015, Webinar
  • FutureTox II: In Vitro Data and In Silico Models for Predictive Toxicology—January 16–17, 2014, Chapel Hill, North Carolina
  • FutureTox: Building the Road for 21st Century Toxicology and Risk Assessment Practices—October 18–19, 2012, Arlington, Virginia
  • PPTOX III: Environmental Stressors in the Developmental Origins of Disease: Evidence and Mechanisms—May 14–16, 2012, Paris, France
  • Building for Better Decisions: Multi-Scale Integration of Human Health and Environmental Data—May 8–11, 2012, US EPA, Research Triangle Park, North Carolina
  • PPTOXII: Role of Environmental Stressors in the Developmental Origins of Disease—December 7–10, 2009, Arlington, Virginia
  • Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance Workshop—December 4–5, 2008, Arlington, Virginia
  • Perfluorinalkyl Acids and Related Chemistries: Toxicokinetics and Mode-of-Action Workshop—February 14–16, 2007, Arlington, Virginia
  • Probabilistic Risk Assessment (PRA): Bridging Components Along the Exposure-Dose-Response Continuum—July 25–27, 2005, Washington D.C.
  • Charting the Future: Building the Scientific Foundation for Mixtures Joint Toxicity and Risk Assessment—February 16–17, 2005, Atlanta, Georgia
  • Joint Specialty Symposium on Renal Toxicology and Toxicology Pathology: An Integration of Mechanistic Investigation and Morphological Evaluation—September 27–October 1, 2004, Lindau / Bodensee, Germany
  • Vaccines: Non-Clinical Safety Evaluation of Preventive Vaccines: Recent Advances and Regulatory Considerations 2002—December 2–4, 2002, Arlington, Virginia
  • Use of Genomic Data in Risk Assessment: State-of-the-Art 2001—November 7–8, 2001, Washington D.C.
  • In Vitro Human Tissue Models in Risk Assessment—September 20–22, 2001
  • Mechanisms of Nephrotoxicity and Nephrocarcinogenicity—April 15–18, 2000, Martha's Vineyard, Maine
  • Harmonization of Cancer and Non-Cancer Risk Assessment—November 1–3, 1999, Arlington, Virginia

Recordings of select past CCT Webinars are available on the SOT Webinars page.